Back

Multi-size electrodes for (hidden) substrate identification in ischemic cardiomyopathy: validation by integration of whole heart histology

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Young Investigator Award - Clinical Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Claire Glashan

Leiden University Medical Center, Leiden (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Prolonged lead dwell time and increased number of leads extracted predict bailout transfemoral lead extraction
Doctor J. Gould (London, GB)
Abstract
Presentation thumbnail
Phospholamban (PLN) p.Arg14del cardiomyopathy: insight into age-related penetrance of cardiac phenotype and malignant ventricular arrhythmias from a large multicenter registry
Mr T. Verstraelen (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Long-term follow-up after an acute myocardial infarction to explore the stability of the arrhythmogenic substrate: the FOOTPRINT study
Doctor B. Jauregui (Zaragoza, ES)
Abstract Slides Video
Presentation thumbnail
Mechanisms of action of cardiac resynchronisation therapy by his bundle pacing in patients with heart failure and LBBB
Doctor A. Arnold (London, GB)
Abstract Slides Video
Presentation thumbnail
Ventricular arrhythmias in cardiac laminopathy: role of cardiac magnetic resonance in risk stratification
Doctor G. Peretto (Milan, IT)
Abstract

Access the full session

Session thumbnail
Young Investigator Award - Clinical

The Event

Event poster

EHRA 2019

17 March - 19 March 2019
You may be interested in
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources